ScienceTechyNews: Tumor-selective angiotensin blockers may improve response to cancer immunotherapy

12:24 PM
A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.

by

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.